Author

Johannes Brettschneider

Observed names: Brettschneider, Johannes, Brettschneider, Johannes 1973-, J Brettschneider, J. Brettschneider, Johannes Brettschneider,

Observed institutions: Universität Ulm, cts CaritasKlinikum Saarbrücken, Herford Hospital, Hertie Foundation, Institute on Aging, University and Rehabilitation Clinics Ulm, University Hospital Ulm, University of Göttingen, University of Pennsylvania

OpenAlex ID: A5113536579

Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

2013 · Johannes Brettschneider, Kelly Del Tredici, et al. · Annals of Neurology · 1,056

PDF

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre

2013 · Jon B. Toledo, Steven E. Arnold, et al. · Brain · 842

Spreading of pathology in neurodegenerative diseases: a focus on human studies

2015 · Johannes Brettschneider, Kelly Del Tredici, et al. · Nature reviews. Neuroscience · 773

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

2012 · Sven Jarius, Klemens Ruprecht, et al. · Journal of Neuroinflammation · 765

PDF

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

2018 · John L Robinson, Edward B Lee, et al. · Brain · 719

Amyotrophic lateral sclerosis—a model of corticofugal axonal spread

2013 · Heiko Braak, Johannes Brettschneider, et al. · Nature Reviews Neurology · 524

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

2015 · Petra Steinacker, Emily Feneberg, et al. · Journal of Neurology Neurosurgery & Psychiatry · 316

Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)

2014 · Johannes Brettschneider, Kelly Del Tredici, et al. · Acta Neuropathologica · 314

TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

2014 · Johannes Brettschneider, Kimihito Arai, et al. · Acta Neuropathologica · 271

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

2012 · Johannes Brettschneider, Jon B. Toledo, et al. · PLoS ONE · 264

PDF

Axonal damage markers in cerebrospinal fluid are increased in ALS

2006 · J. Brettschneider, A. Petzold, et al. · Neurology · 260

Apheresis therapies for NMOSD attacks

2018 · Ingo Kleiter, Anna Gahlen, et al. · Neurology Neuroimmunology & Neuroinflammation · 245

PDF

Deep clinical and neuropathological phenotyping of P ick disease

2015 · David J. Irwin, Johannes Brettschneider, et al. · Annals of Neurology · 204

Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology

2014 · J. Kassubek, H.-P. Muller, et al. · Brain · 198

Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

2015 · Jon B. Toledo, Pallavi Gopal, et al. · Acta Neuropathologica · 183

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

2012 · Jon B. Toledo, Johannes Brettschneider, et al. · Acta Neuropathologica · 183

Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion

2012 · Johannes Brettschneider, Vivianna M. Van Deerlin, et al. · Acta Neuropathologica · 183

Cognitive decline and reduced survival inC9orf72expansion frontotemporal degeneration and amyotrophic lateral sclerosis

2012 · David J Irwin, Corey T McMillan, et al. · Journal of Neurology Neurosurgery & Psychiatry · 154

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

2011 · Johannes Brettschneider, David J. Libon, et al. · Acta Neuropathologica · 140

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

2010 · Johannes Brettschneider, Anne Czerwoniak, et al. · PLoS ONE · 128

PDF

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome

2009 · Johannes Brettschneider, Hayrettin Tumani, et al. · PLoS ONE · 120

PDF

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

2006 · J Brettschneider, A Petzold, et al. · Multiple Sclerosis Journal · 112

Isolated blood–cerebrospinal fluid barrier dysfunction: prevalence and associated diseases

2005 · J. Brettschneider, A. Claus, et al. · Journal of Neurology · 112

miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients

2014 · Bruna De Felice, Anna Annunziata, et al. · Neurogenetics · 111

The chemokine CXCL13 in acute neuroborreliosis

2009 · M. Senel, T. A. Rupprecht, et al. · Journal of Neurology Neurosurgery & Psychiatry · 106

Works count: 126

Citation count: 11,110

H-index: 50

I10-index: 84